Skip to content
AnalystLens

Omega Healthcare Investors 8-K Report, Financial Results (Feb 5, 2025)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed February 5, 2025
Period End
February 5, 2025
Security
OHI
In the record · 2016–202610-K1210-Q348-K126

OHI filed 12 annual reports (10-K), 34 quarterly reports (10-Q) and 126 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · May ’17May ’17
  2. Material agreement8-K · Oct ’20Oct ’20
  3. Leadership change8-K · Jan ’23Jan ’23
  4. Leadership change8-K · Oct ’26Oct ’26

Summary

Summary of the 8-K filed February 5, 2025. Cited figures are marked; the original filing is the authoritative source.

Omega Healthcare Investors, Inc. reported fourth quarter 2024 net income of $116 milliona, or $0.41 per common share, compared with $57 million, or $0.22 per share, in Q4 2023.

Nareit FFO for the quarter was $196 millionb ($0.68 per share) and Adjusted FFO (AFFO) was $214 million ($0.74 per share), up from $173 million ($0.68 per share) a year earlier. For full year 2024, net income was $418 million ($1.55 per diluted share), Nareit FFO was $734 million ($2.71 per share), and AFFO was $778 million ($2.87 per share), compared with $249 million ($1.00 per diluted share), $591 million ($2.36 per share), and $699 million ($2.79 per share) in 2023. Omega completed $340 million of new investments in Q4 2024, comprising $179 million of real estate acquisitions and $162 million of real estate loans, and $1.1 billion of new investments for the full year.

The company issued 34 million common shares for $1.2 billionc in gross proceeds during 2024. As of December 31, 2024, it had $4.9 billion of outstanding indebtedness at a weighted-average annual interest rate of 4.6%, $518.3 million of cash and cash equivalents, and $1.45 billion of undrawn revolving credit capacity. The company repaid $400 million of 4.50% senior notes on January 15, 2025 using balance sheet cash, and extended the maturity of its $1.45 billion revolver and $50 million term loan to October 30, 2025.

For 2025, Omega expects Adjusted FFO of $2.90 to $2.98d per diluted share. Guidance assumes $56 million of asset sales, repayment of the $400 million senior notes due 2025 and a $231 million secured mortgage loan in November 2025, and balance sheet cash of approximately $600 million at December 31, 2025. The board declared a quarterly dividend of $0.67 per share on January 29, 2025.

Key Highlights

  1. Q4 2024 net income was $116 million ($0.41 per share), versus $57 million ($0.22 per share) in Q4 2023; Q4 AFFO was $214 million ($0.74 per share), versus $173 million ($0.68 per share).
  2. Full-year 2024 Nareit FFO was $734 million ($2.71 per share) and AFFO was $778 million ($2.87 per share), compared with $591 million and $699 million in 2023.
  3. Completed $340 million of new investments in Q4 2024 and $1.1 billion for the full year, including the assumption of a $243 million mortgage loan in connection with a JV acquisition.
  4. Issued 34 million common shares for $1.2 billion of gross proceeds in 2024, including 11 million shares for $438 million in Q4.
  5. 2025 Adjusted FFO guidance is $2.90 to $2.98 per diluted share, assuming $56 million of asset sales and balance sheet cash of approximately $600 million at year-end 2025.
  6. Liquidity of $518.3 million in cash and $1.45 billion of undrawn revolver capacity at year-end 2024; the $400 million senior notes due January 15, 2025 were repaid from cash, and the revolver and term loan maturities were extended to October 30, 2025.
  7. Quarterly dividend of $0.67 per share declared January 29, 2025, payable February 18, 2025 to holders of record as of February 10, 2025.

Frequently Asked Questions

  1. How did Omega's earnings and FFO trend in the fourth quarter and full year 2024?

    Net income rose to $116 million ($0.41 per share) in Q4 2024 from $57 million ($0.22 per share) in Q4 2023, and to $418 million ($1.55 per diluted share) for full-year 2024 from $249 million ($1.00 per diluted share) in 2023. Nareit FFO and AFFO also increased on both a quarterly and annual basis. The company attributed the quarterly revenue increase mainly to revenue from new investments and the timing and impact of operator restructurings, and the expense decrease mainly to a recovery in provision for credit losses and lower acquisition-related and interest costs.

  2. What is Omega's 2025 Adjusted FFO guidance and what assumptions support it?

    Omega expects 2025 Adjusted FFO of $2.90 to $2.98 per diluted share. The guidance includes the annual impact of 2024 and year-to-date 2025 acquisitions and assumes quarterly G&A of approximately $12 million to $14 million, $56 million of asset sales, repayment of $400 million of 2025 senior unsecured debt, repayment of a $231 million secured mortgage loan in November 2025, $28 million of loan principal repayments, year-end 2025 cash of approximately $600 million, no material changes in market interest rates, and no additional operators placed on a cash basis for revenue recognition. It excludes additional acquisitions, asset sales, and provisions for credit losses. The company states that it does not provide a reconciliation of this guidance to GAAP net income because forecasting items such as credit loss provisions, impairments, and gains or losses on asset sales is inherently difficult.

  3. How is Omega's balance sheet and leverage positioned?

    At December 31, 2024, Omega had $4.9 billion of outstanding indebtedness at a weighted-average annual interest rate of 4.6%, consisting of $4.2 billion of senior unsecured notes, $478.5 million of unsecured term loans, and $231.1 million of secured debt. It held $518.3 million of cash and $1.45 billion of undrawn revolver capacity. CEO Taylor Pickett said the company reduced leverage from 5 times to below 4 times during 2024. The company repaid $400 million of senior notes on January 15, 2025 with balance sheet cash and extended its revolver and term loan maturities to October 30, 2025, with one remaining option to extend both by six months.

  4. What is the status of key operators such as LaVie and Maplewood?

    LaVie Care Centers filed for Chapter 11 bankruptcy protection in June 2024. Omega committed $10 million of debtor-in-possession financing, of which $6.0 million was outstanding at the end of December 2024, and LaVie paid its full monthly contractual rent of $3.0 million from June 2024 through January 2025. Maplewood Senior Living paid $12.3 million of rent in Q4 2024, compared with $12.1 million in Q3 2024, and paid $4.5 million in January 2025.

  5. What dividend and near-term events were announced?

    The board declared a quarterly cash dividend of $0.67 per share on January 29, 2025, payable February 18, 2025 to holders of record at the close of business on February 10, 2025. Omega's 2024 dividends declared totaled $2.68 per share. The company will host a conference call on Thursday, February 6, 2025 at 10 a.m. Eastern time to review fourth quarter results and current developments.